Intensified antihypertensive therapy is associated with improved survival in type 1 diabetic patients with nephropathy

Journal of Hypertension

Volumn 13, Issue 8, 1995, Pages 933-938

  Sawicki, Peter T ^a   Mühlhauser, Ingrid ^a   Didjurgeit, Ulrike ^a   Baumgartner, Anna ^a   Bender, Ralf ^a   Berger, Michael ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Antihypertensive therapy; Diabetic nephropathy; Hypertension teaching and treatment programme; Mortality; Retinopathy

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CHOLESTEROL; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; BODY MASS; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DIABETIC NEPHROPATHY; DIASTOLIC BLOOD PRESSURE; FEMALE; FOLLOW UP; HEART RATE; HOME MONITORING; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MALE; METABOLIC REGULATION; MORTALITY; PATIENT EDUCATION; PATIENT INFORMATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEINURIA; SURVIVAL; SYSTOLIC BLOOD PRESSURE;

EID: 0029123544     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/00004872-199508000-00015     Document Type: Article

References (30)

1. Borch-Johnson K, Andersen PK, Deckert T: The effect of proteinuria on relative mortality in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1985, 28:590-596.
2. Parving HH, Smidt UM, Friisberg B, Bonnevie-Nielsen V, Andersen AR: A prospective study of glomerular filtration rate and arterial blood pressure in insulin-dependent diabetics with diabetic nephropathy. Diabetologia 1981, 20:457-461.
3. Mogensen CE: Long-term antihypertensive treatment inhibiting the progression of diabetic nephropathy. Br Med j 1982, 285:685-688.
4. Parving H-H, Hommel E: Prognosis in diabetic nephropathy. Br Med J 1989, 299:230-233.
5. Mathiesen ER, Borch-Johnsen K, Jensen DV, Deckert T: Improved survival in patients with diabetic nephropathy. Diabetologia 1989, 32:884-886.
6. MOhlhauser I, Sulzer M, Berger M: Quality assessment of diabetes care according to the recommendations of the St Vincent Declaration: a population-based study in a rural area of Austria. Diabetologia 1992, 35:429-435.
7. Muhlhauser I, Sawicki PT, Didjurgeit U, Jorgens V, Berger M: Uncontrolled hypertension in type 1 diabetes: assessment of patients’ desires about treatment and improvement of blood pressure control by a structured treatment and teaching programme. Diabet Med 1988, 5:693-698.
8. Sawicki PT, Muhlhauser I, Didjurgeit U, Berger M: Improvement of hypertension care by a structured treatment and teaching programme. J Hum Hypertens 1993, 7:10-14.
9. Sawicki PT, Didjurgeit U, Muhlhauser I, Heinemann L, Berger M: Near-normotension and near-normoglycaemia in blind type 1 diabetic patients with overt diabetic nephropathy. J Diabetes Complications 1990, 4:179-183.
10. Muhlhauser I, Bruckner I, Berger M, Cheta D, Jorgens V, lonescu-Tigoviste C, et al.: Evaluation of an intensified insulin treatment and teaching programme as routine management of type 1 (insulin-dependent) diabetes. Diabetologia 1987, 30:681-690.
11. Sawicki PT, Berger M: Measuring progression of diabetic nephropathy [review]. Eur J Clin Invest 1994, 24:651-655.
12. Cox DR: Regression models and life tables [with discussion], J R Statist Soc B 1972; 34:187-220.
13. SAS: SAS/STAT Guide for Personal Computers, version 6. Cary, North Carolina: SAS Institute Inc.; 1987.
14. SAS: SAS Technical Report P-179, Additional SAS/STAT Procedures, release 6.03. Cary, North Carolina: SAS Institute Inc.; 1988.
15. SAS: SAS Technical Report P-217, SAS/STAT Software. The PHREG Procedure, version 6. Cary, North Carolina: SAS Institute Inc.; 1991.
16. Moss SE, Klein R, Klein BEK: Ocular factors in the incidence and progression of diabetic retinopathy. Ophthalmology 1994, 101:77-83.
17. Mühlhauser I: Smoking and diabetes: an update. Diabet Med 1994, 11:336-343.
18. Haynes RB, Gibson ES, Hackett BC, Sackett DL, Taylor DW, Roberts RS: Improvement of medication compliance in uncontrolled hypertension. Lancet 1976, ii: 1265-1268.
19. Kotchen JM, McKean HE, Jackson-Thayer S, Moore RW, Straus R, Kotchen TA: Impact of a rural high blood pressure control program on hypertension control and cardiovascular disease mortality. J Am Med Assoc 1986, 255:2177-2182.
20. Bergstrom J, Alvestrand A, Bucht H, Gutierrez A: Progression of chronic renal failure in man is retarded with more frequent clinical follow-ups and better blood pressure control. Clin Nephrol 1986, 25:1-6.
21. Wilkstrand J, Kendall M: The role of beta receptor blockade in preventing sudden death. Eur Heart J 1992, 13 (suppl D):111-120.
22. Kjekshus J, Gilpin E, Cali G, Blackey AR, Henning H, Ross J: Diabetic patients and beta-blockers after acute myocardial infarction. Eur Heart J 1990, 11:43-50.
23. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD: The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 1993, 329:1456-1462.
24. Bjorck S, Mulec H, Johnsen SA, Norden G, Aurell M: Renal protective effect of enalapril in diabetic nephropathy. Br Med I 1992, 304:339-342.
25. Sawicki PT, Muhlhauser I, Berger M: Captopril, blood pressure, and diabetic nephropathy [letter], J Am Med Assoc 1994, 272:1005.
26. Sawicki PT, Berger M: Renal protective effect of enalapril in diabetic nephropathy. Br Med J 1992, 304:841-842.
27. Bauer JH, Reams GP, Hewett J, Klacho D, Lau A, Messina C, et al. A randomized, double-blind, placebo-controlled trial to evaluate the effect of enalapril in patients with clinical diabetic nephropathy. Am J Kidney Dis 1992, 20:443-457.
28. Elving LD, Wetzels JMF, van Lier HJJ, de Nobel E, Berden JHM: Captopril and atenolol are equally effective in retarding progression of diabetic nephropathy. Diabetologia 1994, 37:604-609.
29. Weidmann P, Boehlen M, de Courten M: Effects of different antihypertensive drugs on human proteinuria. Nephrol Dial Transplant 1993, 8:582-584.
30. Parving HH, Rossing P: The use of antihypertensive agents in prevention and treatment of diabetic nephropathy. Curr Opin Nephrol Hypertens 1994, 3:292-300.